Oxygen Sensing Mesenchymal Progenitors Promote Neo-Vasculogenesis in a Humanized Mouse Model In Vivo
Open Access
- 7 September 2012
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 7 (9) , e44468
Abstract
Despite insights into the molecular pathways regulating hypoxia-induced gene expression, it is not known which cell types accomplish oxygen sensing during neo-vasculogenesis. We have developed a humanized mouse model of endothelial and mesenchymal progenitor co-transplantation to delineate the cellular compartments responsible for hypoxia response during vasculogenesis. Mesenchymal stem/progenitor cells (MSPCs) accumulated nuclear hypoxia-inducible transcription factor (HIF)-1α earlier and more sensitively than endothelial colony forming progenitor cells (ECFCs) in vitro and in vivo. Hypoxic ECFCs showed reduced function in vitro and underwent apoptosis within 24h in vivo when used without MSPCs. Surprisingly, only in MSPCs did pharmacologic or genetic inhibition of HIF-1α abrogate neo-vasculogenesis. HIF deletion in ECFCs caused no effect. ECFCs could be rescued from hypoxia-induced apoptosis by HIF-competent MSPCs resulting in the formation of patent perfused human vessels. Several angiogenic factors need to act in concert to partially substitute mesenchymal HIF-deficiency. Results demonstrate that ECFCs require HIF-competent vessel wall progenitors to initiate vasculogenesis in vivo and to bypass hypoxia-induced apoptosis. We describe a novel mechanistic role of MSPCs as oxygen sensors promoting vasculogenesis thus underscoring their importance for the development of advanced cellular therapies.Keywords
This publication has 57 references indexed in Scilit:
- Principles and mechanisms of vessel normalization for cancer and other angiogenic diseasesNature Reviews Drug Discovery, 2011
- Molecular mechanisms and clinical applications of angiogenesisNature, 2011
- Fibroblast growth factor 9 delivery during angiogenesis produces durable, vasoresponsive microvessels wrapped by smooth muscle cellsNature Biotechnology, 2011
- Hypoxia and InflammationNew England Journal of Medicine, 2011
- Type I collagen, fibrin and PuraMatrix matrices provide permissive environments for human endothelial and mesenchymal progenitor cells to form neovascular networksJournal of Tissue Engineering and Regenerative Medicine, 2011
- Combination of Injectable Multiple Growth Factor–Releasing Scaffolds and Cell Therapy as an Advanced Modality to Enhance Tissue NeovascularizationArteriosclerosis, Thrombosis, and Vascular Biology, 2010
- Empowering self-renewal and differentiation: the role of mitochondria in stem cellsJournal of Molecular Medicine, 2010
- Host Myeloid Cells Are Necessary for Creating Bioengineered Human Vascular Networks In VivoTissue Engineering Part A, 2010
- Mechanism of Improved Cardiac Function After Bone Marrow Mononuclear Cell TherapyCirculation, 2010
- Regulation of angiogenesis by hypoxia: role of the HIF systemNature Medicine, 2003